DAWN — Day One Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00- $2.22bn
- $1.78bn
- $158.18m
U.S. STOCKS ON THE MOVE-IMAX Corp, Volta, Ekso Bionics Holdings
Day One Biopharma surges on promising data for childhood brain cancer drug
Brief: Day One Biopharmaceuticals Inc Files For Mixed Shelf Of Up To $400 Million
Brief: Day One Doses First Patients In Phase 1B/2 Study With Tovorafenib And Pimasertib In RAF-Altered Solid Tumors
U.S. RESEARCH ROUNDUP-First Solar, Henry Schein, Petiq
Brief: Day One Reports Q1 2022 Results And Provides Business Update
U.S. RESEARCH ROUNDUP- Camden Property Trust, Shift4 Payments, Valvoline,
Brief: Day One Reports Fourth Quarter Results And Corporate Progress
Brief: Takeda Pharmaceutical Co Ltd Reports 9.7% Passive Stake In Day One Biopharmaceuticals Inc, As Of December 31, 2021
Brief: Day One Biopharmaceuticals Says First Patient Dosed In Phase 2 Monotherapy Study In Raf-Altered Solid Tumors
U.S. RESEARCH ROUNDUP-Autoweb, Guild Holdings Co, Oceanfirst Financial
Brief: Day One Reports Third Quarter 2021 Financial Results
Brief: Day One Appoints Jaa Roberson As Chief People Officer
Brief: Day One Increased Size Of Board To Eight Directors
Brief: Day One Appoints Scott Garland To Board Of Directors
U.S. RESEARCH ROUNDUP-CF Industries Holdings, DXC Technology Co, Rackspace Technology
U.S. RESEARCH ROUNDUP-Adobe, Goodrx Holdings, PG&E
Day One Biopharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Day One Biopharmaceuticals Posts Quarterly Loss Per Share Of $5.04